Context Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Context Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Context Therapeutics Inc
Rating: 1.78125
Author: Trendlyne DVM scores

about

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, includin...

2.19 -0.14 (-6.01%)

39.50% Fall from 52W High

412.4K

XNAS Volume

XNAS 15 May, 2026 1:43 PM (EDT)

Not Eligible

Expensive Valuation

7.0 / 100

Technically Moderately Bullish

64.3 / 100

No estimates available

Context Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Context Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, includin...

39.50% Fall from 52W High

SWOT Analysis

Context Therapeutics Inc Live Price Chart